ArticleScientific reports2026
FTO-mediated m6A demethylation regulates PGC-1α-dependent mitochondrial biogenesis to attenuate aluminum-induced neuronal senescence.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Aluminum (Al) exposure is increasingly recognized as a risk factor for neurodegenerative disorders; however, the epitranscriptomic mechanisms linking environmental Al toxicity to neuronal senescence and mitochondrial alterations remain poorly understood. We hypothesized that impairs mitochondrial biogenesis and may disrupt mitochondrial homeostasis through dysregulation of N6-methyladenosine (m6A) RNA modification mediated by the m6A demethylase fat mass and obesity-associated protein (FTO). HT22 mouse hippocampal neurons were exposed to aluminum maltolate (60-240 µmol/L). An FTO-overexpression model was established. MeRIP-seq and RNA-seq were performed to assess m6A and transcriptomic changes. Mitochondrial status, particularly mitochondrial biogenesis-related indicators, was evaluated via ATP and mtDNA levels. SA-β-Gal staining assessed senescence. The expression of senescence-associated markers (e.g., p16, p21, HMGA1) and mitochondrial regulatory factors (e.g., FTO, PGC-1α, NRF-1, NRF-2, TFAM) was examined by qPCR and Western blotting. Aluminum exposure globally increased m6A methylation (7,068 peaks upregulated), affecting pathways linked to senescence and neurodegeneration. PGC-1α showed increased m6A and decreased expression. Aging markers (P16, P21, HMGA1) were upregulated, while mitochondrial biogenesis-related indicators (ATP levels, mtDNA copy number, and the PGC-1α axis) were reduced, indicating impaired mitochondrial biogenesis. FTO expression was suppressed by aluminum but overexpression of FTO reversed these effects, reducing m6A levels, restoring PGC-1α expression, partially restoring mitochondrial biogenesis-related parameters, and attenuating senescence. Our findings suggest that aluminum induces neuronal senescence by inhibiting FTO, increasing m6A methylation, and downregulating PGC-1α-mediated mitochondrial biogenesis. The FTO-m6A-PGC-1α axis plays a critical role in aluminum neurotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.